The piroxicam-accelerated colitis in interleukin-10-deficient (IL10−/−) mice is another model where piroxicam (an NSAID) uniformly initiates chronic colitis in IL10−/− mice through epithelial barrier disruption and penetration of luminal bacteria [91]. Here, IL10 is linked to colitis.